lifelancer
The Executive Medical Director, Early Development – Inflammation leads the early development portfolio for key inflammation assets at Amgen, serving as the principal representative to executive leadership, partners, and regulatory agencies. The role is responsible for shaping strategy, overseeing study design and execution, and guiding cross‑functional teams to advance clinical programs while maintaining scientific rigor.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2020
Lifelancer is an AI-powered global talent marketplace that connects life sciences, pharma, biotech, healthtech and IT organizations with freelance, remote and contract specialists. The platform helps employers hire talent and agencies and supports remote hiring and payroll, while listing scientific, consulting and IT roles for candidates. Using AI-driven matching and domain-focused search, Lifelancer streamlines sourcing for R&D, clinical, regulatory and technical functions across the life sciences and technology sectors.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for lifelancer.
33% above the average for this role
Executive Medical Director, Early Dev - Inflammation
Amgen
Medical Senior Director – Early Clinical Development – Inflammation
Amgen
Clinical Scientist Associate Director – Early Development Inflammation
Amgen
Principal Scientist - Inflammation Biomarkers
Amgen
Head of Asset in Gyn, Oncology Clinical Development
AbbVie
Director, Early Development - Clinical Sciences
Tarsus Pharmaceuticals